GO2PHARMACY COM INC
SB-2/A, EX-27.1, 2000-06-28
DAIRY PRODUCTS
Previous: GO2PHARMACY COM INC, SB-2/A, EX-23.3, 2000-06-28
Next: INTERSPACE ENTERPRISES INC, 10QSB, 2000-06-28



<TABLE> <S> <C>


<ARTICLE>                     5

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                              MAR-31-2000
<PERIOD-END>                                   MAR-31-2000
<CASH>                                         0
<SECURITIES>                                   0
<RECEIVABLES>                                  843,020
<ALLOWANCES>                                   115,189
<INVENTORY>                                    1,488,103
<CURRENT-ASSETS>                               2,796,285
<PP&E>                                         1,445,081
<DEPRECIATION>                                 377,266
<TOTAL-ASSETS>                                 4,866,368
<CURRENT-LIABILITIES>                          3,453,813
<BONDS>                                        0
                          1,500,000
                                    0
<COMMON>                                       30,000
<OTHER-SE>                                     (626,812)
<TOTAL-LIABILITY-AND-EQUITY>                   4,866,368
<SALES>                                        5,831,896
<TOTAL-REVENUES>                               5,831,896
<CGS>                                          3,808,640
<TOTAL-COSTS>                                  3,808,640
<OTHER-EXPENSES>                               0
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             317,706
<INCOME-PRETAX>                                (294,556)
<INCOME-TAX>                                   0
<INCOME-CONTINUING>                            (294,556)
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   (294,556)
<EPS-BASIC>                                    (0.10)
<EPS-DILUTED>                                  (0.10)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission